Investor

Taiho Ventures

1 portfolio companies tracked · $77M in latest raises

Overview

1

  • Taiho Ventures is the corporate venture capital arm of Taiho Pharmaceutical, a Japanese pharmaceutical company. The fund focuses on investing in healthcare and life sciences companies, particularly those developing innovative therapies and medical technologies. Taiho Ventures seeks to identify strategic investment opportunities that align with Taiho Pharmaceutical's mission to improve patient outcomes.

Stages

3

Seed Series A Series B

Sectors

3

Healthcare Biotechnology Pharmaceuticals

Geographic focus

2

North America Japan

Portfolio companies

1

Companies from this investor’s TAAFT profile, ranked by latest known raise. Round details come from our company catalog.

Companies
1
Latest raises tracked
$77M
With round data
1
Stages seen
Series B
  • Crossbow Therapeutics

    Biotechnology · United States

    $77M raised
    Series B Announced 5 investors
    Valuation
    $750M

    Announced 13 Mar 2026